21 May 2013
Keywords: teva, gains, rights, gsk, leukemia, drug, israeli-based
Article | 07 July 2003
Israeli-based Teva Pharmaceutical Industries says that it has received all product rights relating to the anticancer drug Purinethol
(mercaptopurine) for ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
7 July 2003
20 May 2013
© 2013 thepharmaletter.com